Laizhu Zhang
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Intratumoral Proton Density Fat Fraction Predicts the Outcome of HAIC Combined With PD-1 Inhibitors in Advanced Hepatocellular Carcinoma.
Journal: Cancer medicine
Published: November 11, 2025
Non-contrast magnetic resonance imaging outperforms contrast-enhanced computed tomography in preoperative detection of hepatocellular carcinoma: A paired validation study.
Journal: Clinical and molecular hepatology
Published: August 18, 2025
Letter to the Editor: Revisiting FOXP3 expression and its prognostic implications in hepatocellular carcinoma.
Journal: Hepatology (Baltimore, Md.)
Published: July 19, 2025
Molecular stratification of hepatocellular carcinoma by metabolic-signaling pathways guides precision immunotherapy and TACE therapy.
Journal: Clinical and molecular hepatology
Published: March 27, 2025
β-catenin mutation reprograms ketone body metabolism to drive hepatocellular carcinoma metastasis and resistance to ketogenic therapy via transcriptional activation of OXCT1.
Journal: Cell death & disease
Published: March 20, 2025
Fat fraction quantification by MRI predicts diagnosis and prognosis of HBV-related steatohepatitic hepatocellular carcinoma.
Journal: European radiology
Published: August 30, 2024
Oxoglutarate dehydrogenase-like inhibits the progression of hepatocellular carcinoma by inducing DNA damage through non-canonical function.
Journal: Cell death and differentiation
Published: February 20, 2023
Multiomics identifies metabolic subtypes based on fatty acid degradation allocating personalized treatment in hepatocellular carcinoma.
Journal: Hepatology (Baltimore, Md.)
Published: October 25, 2022
Last Updated: 09/26/2026